Skip to main content Accessibility help
×
Home

Dosage of Haloperidol for Mania

  • Arthur Rifkin (a1), Seshagiri Doddi (a2), Basawaraj Karajgi (a2), Michael Borenstein (a3) and Ralph Munne (a4)...

Extract

Background

We compared three doses of a neuroleptic as a treatment for mania.

Method

Forty-seven newly admitted in-patients with mania were randomised to receive 10, 30, or 80 mg a day of oral haloperidol, under double-blind conditions for up to six weeks. All subjects received prophylactic benztropine.

Results

Repeated-measures analysis of variance and survival analysis showed no difference in outcome by the different doses. Excluding drop-outs (38%), most of whom left the study during the first two weeks, 72% of the subjects responded. Side-effects were minimal; there were no differences among the three doses. Non-responders received more adjunctive lorazepam than responders.

Conclusions

The limited data suggest that more than 10 mg a day of haloperidol offers no advantage in mania.

Copyright

Corresponding author

Prof. A. Rifkin, Attending Psychiatrist, Hillside Hospital, Long Island Jewish Medical Center, Glen Oaks, NY 11004, USA

References

Hide All
American Psychiatric Association (1980) Diagnostic and Statistical Manual of Mental Disorders (3rd edn) (DSM–III). Washington, DC: American Psychiatric Association.
Baker, L. A., Cheng, L. Y. & Amara, I. B. (1983) The withdrawal of benztropine mesylate in chronic schizophrenic patients. British Journal of Psychiatry, 143, 584590.
Chou, J. C.-Y. (1991) Recent advances in treatment of acute mania. Journal of Clinical Psychopharmacology, 11, 321.
Donlon, P. T., Meadow, A., Tupin, J. P., et al (1978) High vs. standard dosage fluphenazine HCl in acute schizophrenia. Journal of Clinical Psychiatry, 39, 800804.
Donlon, P. T., Hopkin, J. T. & Tupin, J. P. (1980) Haloperidol for acute schizophrenic patients: an evaluation of three oral regimens. Archives of General Psychiatry, 37, 691695.
Endicott, J., Spitzer, R. L. & Fleiss, J. (1976) The Global Assessment Scale: a procedure for measuring overall severity of psychiatric disturbance. Archives of General Psychiatry, 33, 766771.
Ericksen, S., Hurst, S. & Chang, S. (1978) Haloperidol dose, plasma levels, and clinical response: a double-blind study. Psychopharmacology Bulletin, 14, 1516.
Escober, J. I., Barron, A. & Kiriakos, R. (1983) Serum levels of fluphenazine: effect of dosage and route of administration, and relation to side effects and clinical response. Psychopharmacology Bulletin, 19, 131134.
Garfinkel, P. E., Stancer, H. C. & Persad, E. (1980) A comparison of haloperidol, lithium carbonate and their combination in the treatment of mania. Journal of Affectve Disorders, 2, 279288.
Guy, W. (1976) ECDEU Assessment Manual for Psychopharmacology. Washington DC: Department of Health, Education and Welfare Publications (ADM).
Johnson, G., Gershon, S. & Hekimian, L. J. (1968) Controlled evaluation of lithium and chlorpromazine in the treatment of manic states: an interim report. Comprehensive Psychiatry, 9, 563.
Johnson, G., Gershon, S., & Burdock, E. I. (1971) Comparative effects of lithium and chlorpromazine in the treatment of acute manic states. British Journal of Psychiatry, 119, 267.
Johnstone, E. C., Crow, T. J., Ferrier, I. N., et al (1983) Adverse effects of anticholinergic medication on positive schizophrenic symptoms. Psychological Medicine, 13, 513527.
Levinson, D. F., Simpson, G. M., Singh, H., et al (1990) Fluphenazine dose, clinical response, and extrapyramidal symptoms during acute treatment. Arch Gen Psychiatry, 47, 761768.
Manos, N., Gkiouzepas, J. (1981) Discontinuing anti-parkinson medication in chronic schizophrenics. At what cost to the patient? Acta Psychiatrica Scandinavica, 63, 2832.
Manos, N., Gkiouzepas, J. & Logothetis, J. (1981) The need for continuous use of anti-parkinsonian medication within chronic schizophrenic patients receiving long-term neuroleptic therapy. American Journal of Psychiatry, 138, 184188.
McEvoy, J. P., Hogarty, G. E. & Steingard, S. (1991) Optimal dose of neuroleptic in acute schizophrenia: a controlled study of the neuroleptic threshold and higher haloperidol dose. Archives of General Psychiatry, 48, 739745.
Neborsky, R., Janowsky, D., Munson, E., et al (1981) Rapid treatment of acute psychiatric symptoms with high and low dose haloperidol. Archives of General Psychiatry, 38, 195199.
Post, R. M., Jimerson, D. C., Bunney, W. E., et al (1980) Dopamine and mania: behavioral and biochemical effects of the dopamine receptor blocker pimozide. Psychopharmacology, 67, 297305.
Prien, R. F., Caffey, E. M. Jr & Klett, C. J. (1972) A comparison of lithium carbonate and chlorpromazine in the treatment of acute mania. Archives of General Psychiatry, 26, 146153.
Putten, T. Van, Marder, S. R. & Mintz, J. (1990) A controlled dose comparison of haloperidol in newly admitted schizophrenic patients. Archives of General Psychiatry, 47, 754758.
Shopsin, B., Gershon, S. & Thompson, H. (1975) Psychoactive drugs in mania. Archives of General Psychiatry, 32, 3442.
Simpson, G. M. & Anous, J. (1970) A rating scale for extrapyramidal side-effects. Acta Psychiatrica Scandinavica, 212 (suppl.), 1119.
Singh, M. M. & Kay, S. R. (1975) Therapeutic reversal with benztropine in schizophrenics. Journal of Nervous and Mental Disease, 160, 258266.
Manos, N., Gkiouzepas, J. (1979) Therapeutic antagonism between anticholinergic anti-parkinsonian agents with neuroleptics in schizophrenia: implications for a neuropharmacological model. Neuropsychobiology, 5, 7486.
Spitzer, R. L. & Endicott, J. (1978) Schedule for Affective Disorders and Schizophrenia (3rd edn). New York: Biometrics Research Division, New York State Psychiatric Institute.
Wijsenbeeck, H., Steiner, M. & Goldberg, S. C. (1974) Trifluoperazine: a comparison between regular and high doses. Psychopharmacologia, 36, 147150.

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

Dosage of Haloperidol for Mania

  • Arthur Rifkin (a1), Seshagiri Doddi (a2), Basawaraj Karajgi (a2), Michael Borenstein (a3) and Ralph Munne (a4)...
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *